.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Boehringer Ingelheim
Fuji
Dow
Moodys
Johnson and Johnson
Medtronic
Julphar
Merck

Generated: September 20, 2017

DrugPatentWatch Database Preview

Drug Master Files for: ticagrelor

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
28984AII1/14/2015CHANGZHOU PHARMACEUTICAL FACTORYTICAGRELOR
28938AII1/27/2015MSN ORGANICS PRIVATE LTDTICAGRELOR (FORM-II) [ROUTE CODE TG2]
28915AII2/6/2015LEK PHARMACEUTICALS DDTICAGRELOR
28899AII1/9/2015ALEMBIC PHARMACEUTICALS LTDTICAGRELOR
28880AII1/21/2015TEVA PHARMACEUTICAL INDUSTRIES LTDTICAGRELOR
28879AII1/7/2015HONOUR LAB LTDTICAGRELOR
28787AII1/30/2015HEC PHARM CO LTDTICAGRELOR NON-STERILE BULK DRUG SUBSTANCE
28110AII2/20/2014KAIYUAN HENGTAI PHARMA CO LTDTICAGRELOR INTERMEDIATE, 2-((3AR, 4S, 6R, 6AS)-6-AMINO-2, 2-DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA [D] [1,3] DIOXOL-4-YLOXY) ETHANOL L-TARTARIC ACID (1:1) (CAS:37660
28111AII2/20/2014KAIYUAN HENGTAI PHARMA CO LTDTICAGRELOR INTERMEDIATE, 4, 6-DICHLORO-2-(PROPYLTHIO) PYRIMIDINE-5-AMINE (CAS: 145783-15-9)
28112AII2/20/2014KAIYUAN HENGTAI PHARMA CO LTDTICAGRELOR INTERMEDIATE, (1R, 2S) -2- (3,4-DIFLUOROPHENYL) CYCLOPROPANAMINE (R)-2-HYDROXY-2-PHENYLACETATE (1:1) (CAS: 376608-71-8)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Medtronic
Farmers Insurance
Healthtrust
Citi
US Department of Justice
Federal Trade Commission
Accenture
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot